# IGC Pharma (IGC) — Overview

IGC · AMEX · Stock

Canonical page: https://www.lighthorse.io/tickers/igc

## Price

Last close $0.25 on Oct 15, 2026. 52-week range $0.24 – $0.42.

## Company profile

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $1.1M |
| Revenue (quarter) | $869,000.00 |
| Revenue growth (year over year) | 0.00% |
| Gross profit (trailing twelve months) | $511,000.00 |
| Gross margin | 46.20% |
| Net income (trailing twelve months) | −$6.4M |
| Net income (quarter) | −$4.1M |
| Net income growth (year over year) | 0.00% |
| Net margin | -582.82% |
| Return on equity | 0.00% |
| EPS (trailing twelve months) | $0.00 |
| Book value per share | $0.09 |
| P/E (trailing twelve months) | — |
| Price to book | 4.3 |
| Debt to assets | 16.95% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is IGC Pharma (IGC) profitable?

No. IGC Pharma reported a net loss of $6.4M over the trailing twelve months.

### How much revenue does IGC Pharma (IGC) make?

IGC Pharma generated $1.1M in revenue over the trailing twelve months.

### How do I buy stock in IGC Pharma (IGC)?

IGC trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).
